Thoracic Re-irradiation For Locoregionally Recurrent Non-small Cell Lung Cancer
Status:
Recruiting
Trial end date:
2025-02-01
Target enrollment:
Participant gender:
Summary
This prospective phase II study is to assess the efficacy and safety of thoracic
re-irradiation for locoregionally recurrent non-small cell lung cancer using hypofractionated
technique.